Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening

CONCLUSION: Regardless of the cytology results, the risk of CIN 3 or worse was higher in HPV-16/HPV-18 than in other HR-HPV. HPV-16/HPV-18 genotyping is recommended to screen women with a high risk of cervical cancer.PMID:38522949 | DOI:10.3802/jgo.2024.35.e72

Source: Journal of Gynecologic Oncology - March 24, 2024 Category: OBGYN Authors: Eun Hye Cho Min-Seung Park Hee-Yeon Woo Hyosoon Park Min-Jung Kwon Source Type: research